Old Mission Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

Old Mission Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $281,245 - $354,916	490 New	490 $338,000
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $3.63 Million - $4.89 Million	-6,614 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $3.94 Million - $4.62 Million	6,614 New	6,614 $4.62 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $209,108 - $247,038	-562 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $188,730 - $226,508	562 New	562 $210,000
Q1 2018 May 15, 2018	SELL	$315.82 - $393.78 $353,086 - $440,246	-1,118 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $400,948 - $525,404	1,118	1,118 $420,000

1,487

85.7M

1.53M

1.43M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Old Mission Capital LLC with notifications on news.